The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
出版年份 2019 全文链接
标题
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
作者
关键词
-
出版物
Cancers
Volume 11, Issue 7, Pages 1028
出版商
MDPI AG
发表日期
2019-07-22
DOI
10.3390/cancers11071028
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer
- (2019) Yue Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
- (2019) Giacomo Domenici et al. ONCOGENE
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
- (2019) Wenjuan Mei et al. Cancers
- Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells
- (2019) Andrés M. Castellaro et al. Cancers
- FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
- (2019) Lana McClements et al. BMC CANCER
- PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer
- (2019) Angélica Santiago-Gómez et al. CANCER LETTERS
- Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
- (2019) Eunmi Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of Cdc42 and its effectors in epithelial morphogenesis
- (2019) Franck Pichaud et al. JOURNAL OF CELL SCIENCE
- FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
- (2019) Dominika Piasecka et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance
- (2019) Gaurav A. Mehta et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer
- (2019) Marissa Leonard et al. Journal of Zhejiang University-SCIENCE B
- Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review
- (2019) Junjie Li et al. Cancer Medicine
- Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
- (2019) Masahiro Shibata et al. Cancers
- Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
- (2019) Natalia A. Riobo-Del Galdo et al. Cells
- Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells
- (2019) Qi Sun et al. CANCER LETTERS
- Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
- (2018) R J Hartmaier et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer
- (2018) Diane Ojo et al. CANCER LETTERS
- Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines
- (2018) L. Gelsomino et al. CANCER LETTERS
- Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
- (2018) Qiang Wang et al. CELL RESEARCH
- Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer
- (2018) Nami Yamashita et al. Clinical Breast Cancer
- Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
- (2018) Luke Piggott et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cell Phenotypes in ER+Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes
- (2018) Thu H. Truong et al. MOLECULAR CANCER RESEARCH
- The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer
- (2018) Sasha M. Pejerrey et al. Hormones & Cancer
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- SOX9/FXYD3/Src axis is critical for ER+ breast cancer stem cell function
- (2018) Yue Xue et al. MOLECULAR CANCER RESEARCH
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
- (2018) Jonathan T. Lei et al. Cell Reports
- Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
- (2018) Małgorzata Szostakowska et al. BREAST CANCER RESEARCH AND TREATMENT
- Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression
- (2018) Mostafa Nasr et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer
- (2018) Ahmed Basudan et al. MOLECULAR CANCER RESEARCH
- Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer
- (2018) Maria A Papadaki et al. MOLECULAR CANCER THERAPEUTICS
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
- (2017) Ran Ma et al. JNCI-Journal of the National Cancer Institute
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution
- (2017) Ravi G. Gupta et al. MOLECULAR CANCER RESEARCH
- DNA Damage in Stem Cells
- (2017) Ilio Vitale et al. MOLECULAR CELL
- Tumour stem-cell surprises
- (2017) Florian R. Greten NATURE
- A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
- (2017) Felipe de Sousa e Melo et al. NATURE
- Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive
- (2017) Nai Yang Fu et al. NATURE CELL BIOLOGY
- Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
- (2017) Luca Magnani et al. NATURE GENETICS
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
- (2017) S Kitajima et al. ONCOGENE
- Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer
- (2017) Pasquale Sansone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
- (2017) Rinath Jeselsohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
- (2017) Eneda Toska et al. SCIENCE
- Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
- (2017) Jennifer M. Giltnane et al. Science Translational Medicine
- Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway
- (2017) Damián E. Berardi et al. Cancer Research and Treatment
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
- (2017) Ran Ma et al. JNCI-Journal of the National Cancer Institute
- Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
- (2017) Euphemia Y. Leung et al. Frontiers in Oncology
- Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
- (2016) Yijuan Zhang et al. ACS Nano
- FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations
- (2016) Kana Tachi et al. CANCER SCIENCE
- WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells
- (2016) LIANG XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms
- (2016) MARIANNA LAURICELLA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication
- (2016) Samantha Kaufhold et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
- (2016) Xiaoyong Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Study on the expression of PAK4 and P54 protein in breast cancer
- (2016) Yanqing Bi et al. World Journal of Surgical Oncology
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling
- (2016) Li-Fang He et al. Oncotarget
- A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
- (2016) Ahmet Acar et al. Stem Cells International
- mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
- (2015) Govindasamy-Muralidharan Karthik et al. CANCER LETTERS
- Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
- (2015) M. Ruscetti et al. CANCER RESEARCH
- Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
- (2015) P. Wang et al. CLINICAL CANCER RESEARCH
- Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
- (2015) Diane Ojo et al. CURRENT MEDICINAL CHEMISTRY
- Mammary gland development: cell fate specification, stem cells and the microenvironment
- (2015) J. L. Inman et al. DEVELOPMENT
- PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion
- (2015) Anna E. Dart et al. JOURNAL OF CELL BIOLOGY
- Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
- (2015) Muralidharan Anbalagan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- (2015) Ana Bosch et al. Science Translational Medicine
- Implications of stemness-related signaling pathways in breast cancer response to therapy
- (2015) Valentina Angeloni et al. SEMINARS IN CANCER BIOLOGY
- Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- (2015) Van T. M. Nguyen et al. Nature Communications
- p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells
- (2015) Ting Zhuang et al. Oncotarget
- In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays
- (2015) Maurizio Callari et al. Oncotarget
- The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
- (2015) Luca Magnani et al. Oncotarget
- AKT and 14-3-3 Regulate Notch4 Nuclear Localization
- (2015) Gopalakrishnan Ramakrishnan et al. Scientific Reports
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity
- (2015) Bruno M. Simões et al. Cell Reports
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
- (2014) F. Cardoso et al. ANNALS OF ONCOLOGY
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
- (2014) F. Cardoso et al. BREAST
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Roles for Hedgehog signaling in adult organ homeostasis and repair
- (2014) R. Petrova et al. DEVELOPMENT
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
- (2014) Hao Deng et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Delineation of a FOXA1/ER /AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy-Resistant Breast Cancer
- (2014) T. M. Wright et al. MOLECULAR CANCER RESEARCH
- Editorial: Estrogen Receptor Mutations in Breast Cancer—An Anticipated “Rediscovery?”
- (2014) Vincent Giguère MOLECULAR ENDOCRINOLOGY
- In situ identification of bipotent stem cells in the mammary gland
- (2014) Anne C. Rios et al. NATURE
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers
- (2014) Jamunarani Veeraraghavan et al. Nature Communications
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
- (2013) Yan Ni Loh et al. BMC CANCER
- Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
- (2013) Diego Raffo et al. BREAST CANCER RESEARCH AND TREATMENT
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells
- (2013) Alejandro Vazquez-Martin et al. CELL CYCLE
- Wnt signaling in adult intestinal stem cells and cancer
- (2013) Michaela Krausova et al. CELLULAR SIGNALLING
- Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
- (2013) X. H.- F. Zhang et al. CLINICAL CANCER RESEARCH
- Stem cells living with a Notch
- (2013) U. Koch et al. DEVELOPMENT
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Epithelial-mesenchymal plasticity in carcinoma metastasis
- (2013) J. H. Tsai et al. GENES & DEVELOPMENT
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Luminal breast cancer: from biology to treatment
- (2013) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- Silencing MED1 Sensitizes Breast Cancer Cells to Pure Anti-Estrogen Fulvestrant In Vitro and In Vivo
- (2013) Lijiang Zhang et al. PLoS One
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Correlation of Breast Cancer Axillary Lymph Node Metastases With Stem Cell Mutations
- (2013) Cory A. Donovan et al. JAMA Surgery
- Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
- (2013) J Yun et al. Oncogenesis
- An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development
- (2013) Bruce M. Boman et al. Frontiers in Oncology
- Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
- (2012) Julia Y. S. Tsang et al. BREAST CANCER RESEARCH AND TREATMENT
- Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
- (2012) Peter Kabos et al. BREAST CANCER RESEARCH AND TREATMENT
- CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
- (2012) A Dubrovska et al. BRITISH JOURNAL OF CANCER
- Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
- (2012) N. P. A. Devika Gunasinghe et al. CANCER AND METASTASIS REVIEWS
- Highly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway
- (2012) Olaf Hardt et al. CANCER LETTERS
- Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
- (2012) J. Cui et al. CANCER RESEARCH
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
- (2012) Wen Cai Zhang et al. CELL
- Developmental Stage and Time Dictate the Fate of Wnt/β-Catenin-Responsive Stem Cells in the Mammary Gland
- (2012) Renée van Amerongen et al. Cell Stem Cell
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming
- (2012) M. Percharde et al. GENES & DEVELOPMENT
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
- (2012) Rocío García-Becerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
- (2012) Ching-Hung Lin et al. JOURNAL OF CLINICAL PATHOLOGY
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
- (2012) Caryn S. Ross-Innes et al. NATURE
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
- (2012) A. Kreso et al. SCIENCE
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- Fresh Surgical Specimens Yield Breast Stem/Progenitor Cells and Reveal Their Oncogenic Abnormalities
- (2011) SuEllen J. Pommier et al. ANNALS OF SURGICAL ONCOLOGY
- Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
- (2011) Adrian P. Rybak et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Lung Stem Cell Self-Renewal Relies on BMI1-Dependent Control of Expression at Imprinted Loci
- (2011) Sima J. Zacharek et al. Cell Stem Cell
- Sox2+ Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice
- (2011) Katrin Arnold et al. Cell Stem Cell
- Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen
- (2011) Bruno M Simões et al. Future Oncology
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
- (2011) Bao-Hong Guo et al. Molecular Cancer
- Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation
- (2011) D. Yao et al. MOLECULAR CANCER RESEARCH
- A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
- (2011) Hua Tian et al. NATURE
- Distinct stem cells contribute to mammary gland development and maintenance
- (2011) Alexandra Van Keymeulen et al. NATURE
- Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
- (2011) J. M. Haughian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
- (2011) Luca Magnani et al. PLoS Genetics
- Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy
- (2011) Ciara S. O’Brien et al. Hormones & Cancer
- Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
- (2010) Kirsten Vang Nielsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of side population cells from bladder cancer cells by DyeCycle Violet staining
- (2010) Jun Jun She et al. CANCER BIOLOGY & THERAPY
- Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates
- (2010) Ö Yalcin-Ozuysal et al. CELL DEATH AND DIFFERENTIATION
- Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
- (2010) Rita U. Lukacs et al. Cell Stem Cell
- Fulvestrant - A Novel Endocrine Therapy for Breast Cancer
- (2010) S. Johnston et al. CURRENT MEDICINAL CHEMISTRY
- FOXA1 is an essential determinant of ER expression and mammary ductal morphogenesis
- (2010) G. M. Bernardo et al. DEVELOPMENT
- Combining Src inhibitors and aromatase inhibitors: A novel strategy for overcoming endocrine resistance and bone loss
- (2010) Stephen Hiscox et al. EUROPEAN JOURNAL OF CANCER
- Hippo signaling at a glance
- (2010) Bin Zhao et al. JOURNAL OF CELL SCIENCE
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXA1 is a key determinant of estrogen receptor function and endocrine response
- (2010) Antoni Hurtado et al. NATURE GENETICS
- EGFR signaling in breast cancer: Bad to the bone
- (2010) John Foley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Estrogen receptor α geneESR1amplification may predict endocrine therapy responsiveness in breast cancer patients
- (2009) Saori Tomita et al. CANCER SCIENCE
- Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
- (2009) Koji Morimoto et al. CANCER SCIENCE
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
- (2008) P. Rizzo et al. CANCER RESEARCH
- Transcriptome Analysis of the Normal Human Mammary Cell Commitment and Differentiation Process
- (2008) Afshin Raouf et al. Cell Stem Cell
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Lindsay A Brown et al. NATURE GENETICS
- A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability
- (2008) Peter Eirew et al. NATURE MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started